ABCL

Q: What is the price of AbCellera Biologics (ABCL) today?

A cotação de AbCellera Biologics (ABCL) hoje está em $ 4.09, com uma variação de The stock began the year trading around $ 3.42 and is currently priced at $ 4.09. negociando na casa dos $ 3.42 e hoje está em $ 4.09. Acompanhe o and track broader market trends directly on the platform.

Q: When does AbCellera Biologics (ABCL) pay dividends?

AbCellera Biologics (ABCL) did not pay dividends over the past year.

Q: Is AbCellera Biologics (ABCL) a good investment?

Atualmente, AbCellera Biologics (ABCL) está cotada a $ 4.09, com um P/L de -28.71, This represents a -40,000,574% premium compared to its historical average P/E. uma variação de 101.48 em sua cotação e distribuiu $ 0.00 em dividendos, resulting in a dividend yield of 0.00%. The total shareholder return over the same period was 101.48%.Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

AbCellera Biologics Inc.

Price

$ 4.09

return (12m)

101.48%

p/e

-28.71

p/bv

1.32

DIVIDEND YIELD

0.00%

ABCL price

ABCL

If you had invested

years ago

7 days

30 days

6 months

YTD

1 year

5 years

10 years

15 years

ago, you would now have *

ago, you would now have:

*The figure considers the reinvestment of dividends.

Return on Investment ABCL

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

2.00%

3 months

31.94%

1 year

101.48%

2 years

12.36%

5 years

-87.60%

10 years

0.00%

Fundamentals ABCL

review the fundamentals of AbCellera Biologics shares

P/E

-28.71

Sector: -5.24 Industry: -0.08

P/S (PSR)

149.13

Sector: 5.70 Industry: 6.83

P/BV

1.32

Sector: 2.05 Industry: 2.31

DIVIDEND YIELD (DY)

0.00%

Sector: - Industry: -

ROA

-3.30%

Sector: -12.31% Industry: -11.21%

ROE

-4.60%

Sector: -13.06% Industry: -11.48%

ROIC

-23.69%

Sector: -429.08% Industry: -92.89%

NET MARGIN

-100.00%

Sector: -27.99% Industry: -29.53%

GROSS MARGIN

100.00%

Sector: 45.76% Industry: 50.66%

OPERATING MARGIN

-100.00%

Sector: -25.89% Industry: -27.81%

EV/EBITDA

-27.83

Sector: -0.48 Industry: 3.06

EV/EBIT

-23.30

Sector: -5.74 Industry: 2.05

PRICE-TO-ASSETS

0.95

Sector: 1.13 Industry: 1.28

BVPS

3.10

Sector: 3.94 Industry: 5.19

EPS

-0.14

Sector: -0.41 Industry: -0.30

EQUITY-TO-ASSETS RATIO

0.72

Sector: 0.44 Industry: 0.46

LIABILITIES / ASSETS

0.28

Sector: 0.47 Industry: 0.51

CAGR REVENUE 5 YEARS

-26.74%

Sector: - Industry: -

CAGR PROFIT 5 YEARS

0.00%

Sector: - Industry: -

Fundamentals ABCL

DRAG THE FRAME TO SEE MORE DATA

Stock Comparison Tool

DRAG THE FRAME TO SEE MORE DATA

	p/e	p/bv	ROE	dy	market cap	net margin
LLY	121.47	28.80	23.71%	0.62%	$ 898.40 B	37.36%
ISRG	181.98	8.50	4.67%	0.00%	$ 149.50 B	29.65%
TMO	98.77	3.13	3.17%	0.40%	$ 163.06 B	15.00%
SNY	44.47	1.24	2.79%	5.18%	$ 104.21 B	7.89%
NVS	89.57	7.26	8.11%	2.10%	$ 282.68 B	23.34%
ABT	25.14	0.00	0.00%	2.64%	$ 157.79 B	13.91%
MDT	85.48	1.99	2.32%	3.73%	$ 97.70 B	12.68%
GSK	42.79	4.27	9.97%	3.56%	$ 99.09 B	22.77%
CVS	41.48	1.57	3.79%	2.77%	$ 122.07 B	2.93%
BSX	21.94	3.00	13.66%	0.00%	$ 78.23 B	17.29%
TMDX	293.55	4.35	1.48%	0.00%	$ 2.15 B	4.21%
HCA	58.49	-31.82	-54.40%	0.70%	$ 94.75 B	8.48%
IDXX	151.92	27.19	17.89%	0.00%	$ 42.30 B	24.41%
RMD	73.41	4.51	6.14%	1.15%	$ 29.27 B	27.86%
DHR	111.40	2.16	1.94%	0.84%	$ 114.63 B	17.29%
INMD	75.75	1.32	1.75%	0.00%	$ 875.70 M	14.09%
PHG	137.64	1.82	1.32%	3.51%	$ 24.03 B	3.87%
VTRS	107.91	1.30	1.20%	2.91%	$ 19.03 B	5.02%
SYK	157.25	5.10	3.24%	1.12%	$ 117.15 B	12.38%
FMS	87.46	0.72	0.83%	3.64%	$ 11.88 B	2.55%

Stock vs Indice Comparison Tool

If you had invested

years ago

2 years

5 years

10 years

ago, you would now have *

ago, you would now have:

*The value considers the reinvestment of dividends.

ABCL Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT AbCellera Biologics

AbCellera Biologics Inc.

Average Investor10 user rating

4.0 (7 people)

United States

14 years

Founded: 2012

2020

Time since IPO - 6 years

206

Employees

AbCellera Biologics Inc. (United States) is listed on the Nasdaq and has a market capitalization of $1.24 Billion, with shareholders equity totaling $938.08 Millions.

The company employs approximately 206 people and operates in the Health sector, within the Life Science Tools and Services industry.

Over the past 12 months, AbCellera Biologics Inc. reported $79.20 Millions in revenue, generating net income of $-143.96 Millions.

Key financial metrics include a P/E ratio of -28.71, a price-to-book (P/B) ratio of 1.32, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker ABCL.

Market cap

$ 1.24 Billion

Net worth

$ 938.08 Millions

$ 938,080,000.00

Assets

$ 1.31 Billion

$ 1,307,110,000.00

Total Shares Outstanding

303.00 Millions

303,000,000

Average Daily Trading Volume

$ 5.36 Millions

$ 5,356,060.70

Sector

Health

Industry

Life Science Tools and Services

ABCL

ABCL revenue and profits

Financial Results ABCL

DRAG THE FRAME TO SEE MORE DATA

ABCL cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more stocks

CVS - CVS Health

$ 95.89 58,97% (12M)

P/E

41.48

2.77%

ROE

3.79%

P/BV

1.57

CI - Cigna

$ 285.27 --8,74% (12M)

P/E

45.53

2.13%

ROE

3.90%

P/BV

1.77

CNC - Centene

$ 58.27 --5,68% (12M)

P/E

18.60

0.00%

ROE

7.16%

P/BV

1.33

HUM - Humana

$ 305.12 30,62% (12M)

P/E

30.87

1.16%

ROE

6.36%

P/BV

1.96

SNY - Sanofi

$ 42.69 --10,34% (12M)

P/E

44.47

5.18%

ROE

2.79%

P/BV

1.24

LLY - Eli Lilly

$ 1,004.92 34,28% (12M)

P/E

121.47

0.62%

ROE

23.71%

P/BV

28.80

HCA - HCA Healthcare

$ 423.00 10,09% (12M)

P/E

58.49

0.70%

ROE

-54.40%

P/BV

-31.82

NVS - Novartis

$ 148.08 37,75% (12M)

P/E

89.57

2.10%

ROE

8.11%

P/BV

7.26